Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

SODIUM CHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Sodium Chloride, and when can generic versions of Sodium Chloride launch?

Sodium Chloride is a drug marketed by Abbott, B Braun, Miles, Baxter Hlthcare, Hospira, Icu Medcl, Medefil Inc, West-ward Pharms Int, Taro, Fresenius Kabi Usa, Haemonetics, Jubilant Hollistrstr, Liebel-flarsheim, Fresenius Medcl, and Abraxis Pharm. and is included in forty-three NDAs.

The generic ingredient in SODIUM CHLORIDE is potassium chloride; sodium chloride. There are two hundred and twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

Summary for Tradename: SODIUM CHLORIDE

Patents:0
Applicants:15
NDAs:43
Bulk Api Vendors: see list126
Clinical Trials: see list1,055
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SODIUM CHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION019465-002Jul 15, 1985APRXYesNo► Subscribe► Subscribe
Haemonetics
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION076316-001Oct 27, 2004APRXNoNo► Subscribe► Subscribe
Fresenius Medcl
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION078177-001Apr 12, 2007APRXNoNo► Subscribe► Subscribe
Hospira
SODIUM CHLORIDE IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION018897-001Jul 20, 1984RXYesNo► Subscribe► Subscribe
Liebel-flarsheim
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION021569-001Jul 27, 2006RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot